vs
Side-by-side financial comparison of EGAIN Corp (EGAN) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
EGAIN Corp is the larger business by last-quarter revenue ($23.0M vs $13.2M, roughly 1.7× TriSalus Life Sciences, Inc.). EGAIN Corp runs the higher net margin — 10.2% vs -73.9%, a 84.0% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 2.6%). EGAIN Corp produced more free cash flow last quarter ($9.9M vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 1.4%).
Headquartered in Sunnyvale, California, eGain Corporation helps businesses automate customer and employee experience with its AI knowledge software.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
EGAN vs TLSI — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.0M | $13.2M |
| Net Profit | $2.3M | $-9.8M |
| Gross Margin | 73.1% | 86.7% |
| Operating Margin | 8.9% | -24.8% |
| Net Margin | 10.2% | -73.9% |
| Revenue YoY | 2.6% | 59.8% |
| Net Profit YoY | 248.1% | 3.5% |
| EPS (diluted) | $0.08 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.0M | $13.2M | ||
| Q3 25 | $23.5M | $11.6M | ||
| Q2 25 | $23.2M | $11.2M | ||
| Q1 25 | $21.0M | $9.2M | ||
| Q4 24 | $22.4M | $8.3M | ||
| Q3 24 | $21.8M | $7.3M | ||
| Q2 24 | $22.5M | $7.4M | ||
| Q1 24 | $22.4M | $6.5M |
| Q4 25 | $2.3M | $-9.8M | ||
| Q3 25 | $2.8M | $-10.8M | ||
| Q2 25 | $30.9M | $-8.3M | ||
| Q1 25 | $66.0K | $-10.4M | ||
| Q4 24 | $671.0K | $-10.1M | ||
| Q3 24 | $652.0K | $-2.4M | ||
| Q2 24 | $1.5M | $-4.3M | ||
| Q1 24 | $1.5M | $-13.2M |
| Q4 25 | 73.1% | 86.7% | ||
| Q3 25 | 75.2% | 83.5% | ||
| Q2 25 | 72.7% | 83.9% | ||
| Q1 25 | 68.0% | 83.7% | ||
| Q4 24 | 70.2% | 85.3% | ||
| Q3 24 | 69.4% | 86.3% | ||
| Q2 24 | 69.3% | 87.6% | ||
| Q1 24 | 69.3% | 85.0% |
| Q4 25 | 8.9% | -24.8% | ||
| Q3 25 | 12.1% | -77.9% | ||
| Q2 25 | 14.0% | -65.4% | ||
| Q1 25 | 0.1% | -79.9% | ||
| Q4 24 | 2.9% | -91.8% | ||
| Q3 24 | 2.3% | -118.9% | ||
| Q2 24 | 5.3% | -111.0% | ||
| Q1 24 | 4.2% | -180.8% |
| Q4 25 | 10.2% | -73.9% | ||
| Q3 25 | 12.0% | -93.5% | ||
| Q2 25 | 132.8% | -73.9% | ||
| Q1 25 | 0.3% | -113.2% | ||
| Q4 24 | 3.0% | -122.4% | ||
| Q3 24 | 3.0% | -32.6% | ||
| Q2 24 | 6.7% | -58.8% | ||
| Q1 24 | 6.7% | -204.5% |
| Q4 25 | $0.08 | $-0.22 | ||
| Q3 25 | $0.10 | $-0.96 | ||
| Q2 25 | $1.09 | $-0.27 | ||
| Q1 25 | $0.00 | $-0.39 | ||
| Q4 24 | $0.02 | $-0.38 | ||
| Q3 24 | $0.02 | $-0.12 | ||
| Q2 24 | $0.05 | $-0.21 | ||
| Q1 24 | $0.05 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $83.1M | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $88.8M | $-33.9M |
| Total Assets | $146.8M | $35.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $83.1M | $20.4M | ||
| Q3 25 | $70.9M | $22.7M | ||
| Q2 25 | $62.9M | $26.5M | ||
| Q1 25 | $68.7M | $13.0M | ||
| Q4 24 | $70.5M | $8.5M | ||
| Q3 24 | $67.2M | $11.3M | ||
| Q2 24 | $70.0M | $16.5M | ||
| Q1 24 | $83.0M | $4.0M |
| Q4 25 | $88.8M | $-33.9M | ||
| Q3 25 | $83.5M | $-26.7M | ||
| Q2 25 | $80.7M | $-19.4M | ||
| Q1 25 | $51.6M | $-34.4M | ||
| Q4 24 | $55.3M | $-25.9M | ||
| Q3 24 | $55.7M | $-20.4M | ||
| Q2 24 | $58.5M | $-25.3M | ||
| Q1 24 | $63.9M | $-36.0M |
| Q4 25 | $146.8M | $35.3M | ||
| Q3 25 | $144.6M | $36.5M | ||
| Q2 25 | $148.0M | $41.3M | ||
| Q1 25 | $106.2M | $28.6M | ||
| Q4 24 | $111.3M | $24.0M | ||
| Q3 24 | $114.9M | $27.5M | ||
| Q2 24 | $127.9M | $32.4M | ||
| Q1 24 | $120.3M | $17.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $10.1M | $-2.5M |
| Free Cash FlowOCF − Capex | $9.9M | $-2.5M |
| FCF MarginFCF / Revenue | 43.0% | -19.1% |
| Capex IntensityCapex / Revenue | 1.0% | 0.3% |
| Cash ConversionOCF / Net Profit | 4.33× | — |
| TTM Free Cash FlowTrailing 4 quarters | $17.6M | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.1M | $-2.5M | ||
| Q3 25 | $10.4M | $-3.7M | ||
| Q2 25 | $-4.3M | $-7.3M | ||
| Q1 25 | $2.2M | $-4.5M | ||
| Q4 24 | $6.4M | $-5.7M | ||
| Q3 24 | $954.0K | $-10.8M | ||
| Q2 24 | $-5.1M | $-13.4M | ||
| Q1 24 | $1.7M | $-10.9M |
| Q4 25 | $9.9M | $-2.5M | ||
| Q3 25 | $10.2M | $-3.9M | ||
| Q2 25 | $-4.5M | $-7.4M | ||
| Q1 25 | $2.1M | $-5.3M | ||
| Q4 24 | $6.3M | $-5.8M | ||
| Q3 24 | $845.0K | $-11.0M | ||
| Q2 24 | $-5.2M | $-13.5M | ||
| Q1 24 | $1.7M | $-10.9M |
| Q4 25 | 43.0% | -19.1% | ||
| Q3 25 | 43.4% | -33.9% | ||
| Q2 25 | -19.5% | -66.1% | ||
| Q1 25 | 10.0% | -57.3% | ||
| Q4 24 | 28.1% | -69.7% | ||
| Q3 24 | 3.9% | -149.9% | ||
| Q2 24 | -23.0% | -183.1% | ||
| Q1 24 | 7.8% | -169.3% |
| Q4 25 | 1.0% | 0.3% | ||
| Q3 25 | 1.0% | 1.9% | ||
| Q2 25 | 0.9% | 0.8% | ||
| Q1 25 | 0.5% | 8.2% | ||
| Q4 24 | 0.6% | 0.6% | ||
| Q3 24 | 0.5% | 2.3% | ||
| Q2 24 | 0.2% | 0.8% | ||
| Q1 24 | 0.1% | 1.0% |
| Q4 25 | 4.33× | — | ||
| Q3 25 | 3.70× | — | ||
| Q2 25 | -0.14× | — | ||
| Q1 25 | 33.48× | — | ||
| Q4 24 | 9.57× | — | ||
| Q3 24 | 1.46× | — | ||
| Q2 24 | -3.40× | — | ||
| Q1 24 | 1.17× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EGAN
| Transferred Over Time | $22.0M | 96% |
| Technology Service | $1.2M | 5% |
TLSI
Segment breakdown not available.
